A novel therapeutic pathway to the human cochlear nerve
- PMID: 39500916
- PMCID: PMC11538549
- DOI: 10.1038/s41598-024-74661-5
A novel therapeutic pathway to the human cochlear nerve
Abstract
Traditional approaches to the human cochlear nerve have been impeded by its bony encasement deep inside the skull base. We present an innovative, minimally invasive, therapeutic pathway for direct access to the nerve to deliver novel regenerative therapies. Neuroanatomical studies on 10 cadaveric human temporal bones were undertaken to identify a potentially safe therapeutic pathway to the cochlear nerve. Simulations based on three-dimensional delineation of anatomical structures obtained from synchrotron phase-contrast imaging were analyzed. This enabled the identification of an approach to the nerve in the fundus of the internal auditory meatus by trephining the medial modiolar wall of the cochlea via the round window for a median depth of 1.48 mm (range 1.21-1.91 mm). The anatomical access was validated on 9 additional human temporal bones using radio-opaque markers and contrast injection with micro-computed tomography surveillance. We thus created an effective conduit for the delivery of therapeutic agents to the cochlear nerve.
Keywords: Cochlear nerve; Deafness; Gene Therapy; Human; Micro-CT; Stem cell therapy; Synchrotron Imaging.
© 2024. The Author(s).
Conflict of interest statement
Prof. Marcelo Rivolta is the Founder Director and Chief Scientific Officer of Rinri Therapeutics. Prof. Douglas Hartley is Rinri Therapeutics Chief Medical Officer. Other authors do not have any competing interest.
Figures







References
-
- WHO World Report on Hearing 2021.
-
- Hudspeth, A. J. Integrating the active process of hair cells with cochlear function. Nat. Rev. Neurosci. 2014 159 15, 600–614 (2014). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources